Medullary thyroid carcinoma (MTC) and RET proto-oncogene: Mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form

被引:57
|
作者
Figlioli, Gisella [1 ]
Landi, Stefano [1 ]
Romei, Cristina [2 ]
Elisei, Rossella [2 ]
Gemignani, Federica [1 ]
机构
[1] Univ Pisa, Dept Biol, I-56124 Pisa, Italy
[2] Univ Pisa, Dept Endocrinol, I-56124 Pisa, Italy
关键词
Medullary thyroid carcinoma; RET gene mutations; RET gene polymorphisms; Meta-analysis; ENDOCRINE NEOPLASIA TYPE-2; CODON; 918; MUTATION; GERMLINE-SEQUENCE VARIANTS; TYROSINE KINASE ACTIVATION; TERM-FOLLOW-UP; PROGNOSTIC-FACTORS; MEN; 2A; MULTIVARIATE-ANALYSIS; DISEASE PHENOTYPE; CLINICOPATHOLOGICAL FEATURES;
D O I
10.1016/j.mrrev.2012.09.002
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Medullary thyroid carcinoma (MTC) is an uncommon malignant tumor arising from the calcitonin-producing parafollicular cells (C cells) of thyroid. It accounts for 5-10% of all thyroid cancers, and it mostly occurs as a sporadic entity (sMTC), but a familial pattern (fMTC) is also possible. RET protooncogene germline mutations are crucial for the onset and the progression of fMTC, and the occurrence of single nucleotide polymorphisms could predispose to the sporadic form. In order to clarify the role of this gene in MTC, we carefully reviewed the PubMed database using appropriate terms. First, we summarized current knowledge of the germline RET mutations, mutation spectrum, and prevalence. We then performed a meta-analysis on the available case-control association studies for sMTC. Finally, we carried out in silico predictions of the best associated variants in the attempt to better define their role in the disease. To date, a total of 39 different RET germline mutations have been identified in fMTC families. The most affected codons are 609, 611, 618, 620 (exon 10) and 634 (exon 11), encoding for the extracellular cysteine-rich domain, and codons 768 (exon 13) and 804 (exon 14) of the intracellular tyrosine kinase domain. Six polymorphisms with at least three studies were included in the meta-analysis (A45A [rs1800858], G691S [rs1799939], L769L [rs1800861 I, S836S [rs1800862], S904S [rs1800863], and IVS1-126G>T [rs2565206]). The meta-analysis demonstrated a modest association of sMTC susceptibility with S836S and a strong association with the IVS1-126G>T polymorphism. Besides RET polymorphisms, we also investigated the role of a few other low-penetrance alleles of genes involved in the RET pathway or in xenobiotic metabolism, but none of these were confirmed. Thus, despite the well-known molecular basis of fMTC, the genetic variants of the sporadic form are still poorly understood, and functional analyses are needed to better understand the consequence of such RET variants and to improve our knowledge on the disease. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:36 / 44
页数:9
相关论文
共 50 条
  • [31] Ret proto-oncogene mutations in apparently sporadic Turkish medullary thyroid carcinoma patients: Turkmen study
    M. F. Erdogan
    A. Gürsoy
    G. Özgen
    M. Çakir
    F. Bayram
    R. Ersoy
    E. Algün
    B. Çetinarslan
    A. Çömlekçi
    P. Kadıoglu
    M. K. Balci
    I. Yetkin
    T. Kabalak
    G. Erdogan
    Journal of Endocrinological Investigation, 2005, 28 : 806 - 809
  • [32] Nationwide survey and analysis of the RET proto-oncogene in inherited medullary thyroid carcinoma in Japan
    Takami, H
    FAMILIAL CANCER AND PREVENTION: MOLECULAR EPIDEMIOLOGY - A NEW STRATEGY TOWARD CANCER CONTROL, 1999, : 371 - 375
  • [33] Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma
    Shirahama, S
    Ogura, K
    Takami, H
    Ito, K
    Tohsen, T
    Miyauchi, A
    Nakamura, Y
    JOURNAL OF HUMAN GENETICS, 1998, 43 (02) : 101 - 106
  • [34] Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma
    Chiefari, E
    Russo, D
    Giuffrida, D
    Zampa, GA
    Meringolo, D
    Arturi, F
    Chiodini, I
    Bianchi, D
    Attard, M
    Trischitta, V
    Bruno, R
    Giannasio, P
    Pontecorvi, A
    Filetti, S
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1998, 21 (06) : 358 - 364
  • [35] Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma
    E. Chiefari
    D. Russo
    D. Giuffrida
    G. A. Zampa
    D. Meringolo
    F. Arturi
    I. Chiodini
    D. Bianchi
    M. Attard
    V. Trischitta
    R. Bruno
    P. Giannasio
    A. Pontecorvi
    Sebastiano Filetti
    Journal of Endocrinological Investigation, 1998, 21 : 358 - 364
  • [36] Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma
    Syuya Shirahama
    K. Ogura
    Hiroshi Takami
    Kunihiko Ito
    Tohichi Tohsen
    Akira Miyauchi
    Yusuke Nakamura
    Journal of Human Genetics, 1998, 43 : 101 - 106
  • [37] Molecular analysis of the RET proto-oncogene in patients with sporadic medullary thyroid carcinoma: A novel point mutation in the extracellular cysteine-rich domain
    Bugalho, MJ
    Frade, JP
    Santos, JR
    Limbert, E
    Sobrinho, L
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 136 (04) : 423 - 426
  • [38] Germline and somatic mutations of the RET proto-oncogene in apparently sporadic medullary thyroid carcinomas
    Scurini, C
    Quadro, L
    Fattoruso, O
    Verga, U
    Libroia, A
    Lupoli, G
    Cascone, E
    Marzano, L
    Paracchi, S
    Busnardo, B
    Girelli, ME
    Bellastella, A
    Colantuoni, V
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 137 (01) : 51 - 57
  • [39] Papillary thyroid carcinoma in patients with RET proto-oncogene germline mutation
    Brauckhoff, M
    Gimm, O
    Hinze, R
    Ukkat, J
    Brauckhoff, K
    Dralle, H
    THYROID, 2002, 12 (07) : 557 - 561
  • [40] 27-bp Deletion in the ret proto-oncogene as a somatic mutation associated with medullary thyroid carcinoma
    Viatcheslaw Kalinin
    A. Frilling
    Journal of Molecular Medicine, 1998, 76 : 365 - 367